Clinical Trials Directory

Trials / Conditions / Gastroesophageal Junction

Gastroesophageal Junction

7 registered clinical trials studyying Gastroesophageal Junction — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingUsing 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
NCT07217704
SOFIEPhase 3
Not Yet RecruitingPucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junct
NCT07092449
Tang-Du HospitalN/A
RecruitingSubstudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants
NCT06469944
Merck Sharp & Dohme LLCPhase 1 / Phase 2
RecruitingSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-
NCT06445972
Merck Sharp & Dohme LLCPhase 1 / Phase 2
CompletedTreatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
NCT05411133
Arbele Pty LtdPhase 1
WithdrawnAn Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Ther
NCT03704077
Bristol-Myers SquibbPhase 2
Active Not RecruitingMAGE-A4ᶜ¹º³²T for Multi-Tumor
NCT03132922
AdaptimmunePhase 1